Click to return to home page

About IMS Global Services

IMS provide the answers

IMS provide Market Insight

Industry events, conferences and links

Our complete product range

Latest news and press releases

Addresses, phone numbers and emails

 

 


Definition of Megabrand

According to AstraZeneca, a megabrand is a product that has the following characteristics:

  • Reaches $1 billion in annual sales by year two of launch and is clearly destined to achieve peak sales of several billion dollars
  • Requires a rapid global roll-out to around 60 countries within that two-year period
  • Needs a huge marketing investment. The marketing commitment that AstraZeneca surmises is necessary is $450 million - $1 billion in the first two years of launch, with 25% of that being spent pre-launch (and in addition to development spending). The commercial risk inherent in such an investment is significant and suggests that only the very largest companies can participate at this level.
02 Mar 2000, Copyright IMS HEALTH
See Also: Recent Blockbuster History
Therapeutic Categories offering Megabrand Potential
AstraZeneca's Potential Megabrands
Positioning of small Companies with the 'Megabrand Scenario'
The Trend Towards Megabrands
External links:

<< Back to Market Insight